{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:38:13Z","timestamp":1791308293527,"version":"4.3.1"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Oral lichen planus (OLP) is an inflammatory disease of the oral mucosa. Clinically, two main subsets are described, namely non-erosive and erosive OLP. While non-erosive OLP is usually responsive to local therapies, erosive OLP is often refractory also to systemic therapies and extremely reduces the quality of life of the patients. Furthermore, in some erosive OLP cases different autoantibodies have been detected, including anti-desmoglein 1 and 3 autoantibodies, and anti-bullous pemphigoid 180 and 230 autoantibodies. However, their potential role is still not clear. In this paper, we reviewed the literature about the detection of autoantibodies against desmoglein 1 and 3, the main target antigens of pemphigus vulgaris, in patient with OLP, summarizing the more recent insights on this topic.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1001970","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T16:49:28Z","timestamp":1664815768000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Detection of anti-desmoglein antibodies in oral lichen planus: What do we know so far"],"prefix":"10.3389","volume":"13","author":[{"given":"Dario","family":"Didona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hertl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.875492","article-title":"Unmet medical needs in chronic, non-communicable inflammatory skin diseases","volume":"9","author":"Ujiie","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14565","article-title":"Lichen planus - a clinical guide","volume":"19","author":"Solimani","year":"2021","journal-title":"J Dtsch Dermatol Ges"},{"key":"B3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12903-022-02168-4","article-title":"Oral lichen planus: comparative efficacy and treatment costs-a systematic review","volume":"22","author":"Sandhu","year":"2022","journal-title":"BMC Oral Health"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01808","article-title":"Therapeutic targeting of Th17\/Tc17 cells leads to clinical improvement of lichen planus","volume":"10","author":"Solimani","year":"2019","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-016-1667-2","article-title":"Oral lichen planus: a literature review and update","volume":"308","author":"Alrashdan","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12918","article-title":"Oral lichen planus: an update on its pathogenesis","volume":"54","author":"Nogueira","year":"2015","journal-title":"Int J Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01418","article-title":"Pemphigus: Current and future therapeutic strategies","volume":"10","author":"Didona","year":"2019","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s00105-022-05036-y","article-title":"Bull\u00f6se autoimmundermatosen der schleimhaut","volume":"73","author":"Didona","year":"2022","journal-title":"Dermatologie (Heidelb)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.23736\/S2784-8671.20.06790-5","article-title":"Pemphigus: a critical analysis on clinical subtypes, pathogenesis, diagnostics and established novel therapeutics","volume":"156","author":"Eming","year":"2021","journal-title":"Ital J Dermatol Venerol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL_182_17","article-title":"A study of prevalence of autoantibodies in patients with lichen planus from Mumbai, India","volume":"84","author":"Rambhia","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"B11","article-title":"Serum autoantibodies to desmogleins 1 and 3 in patients with oral lichen planus","volume":"47","author":"Lukac","year":"2006","journal-title":"Croat Med J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12990","article-title":"Epithelial antigenic specificities of circulating autoantibodies in mucosal lichen planus","volume":"55","author":"Herrero-Gonz\u00e1lez","year":"2016","journal-title":"Int J Dermatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1684\/ejd.2007.0090","article-title":"Introducing a novel autoimmune bullous skin disorder intensity score (ABSIS) in pemphigus","volume":"17","author":"Pf\u00fctze","year":"2007","journal-title":"Eur J Dermatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12661","article-title":"Oral lichen planus with antibodies to desmogleins 1 and 3","volume":"42","author":"Kinjyo","year":"2015","journal-title":"J Dermatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13493","article-title":"Two cases of erosive oral lichen planus with autoantibodies to desmoglein 3","volume":"43","author":"Muramatsu","year":"2016","journal-title":"J Dermatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-017-1756-x","article-title":"Autoantibodies to desmogleins 1 and 3 in patients with lichen planus","volume":"309","author":"Vahide","year":"2017","journal-title":"Arch Dermatol Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.tripleo.2004.07.013","article-title":"Scoring system for monitoring oral lichenoid lesions: a preliminary study","volume":"99","author":"Piboonniyom","year":"2005","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"B18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jaci.2018.02.044","article-title":"TH1\/TH17 cell recognition of desmoglein 3 and bullous pemphigoid antigen 180 in patients with lichen planus","volume":"142","author":"Schmidt","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00779","article-title":"Humoral epitope spreading in autoimmune bullous diseases","volume":"9","author":"Didona","year":"2018","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1001970\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T16:49:30Z","timestamp":1664815770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1001970\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":19,"alternative-id":["10.3389\/fimmu.2022.1001970"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1001970","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,3]]},"article-number":"1001970"}}